Transamerica Financial Advisors Inc. lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,250 shares of the medical equipment provider’s stock after selling 312 shares during the period. Transamerica Financial Advisors Inc.’s holdings in Intuitive Surgical were worth $5,872,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical during the 4th quarter valued at $82,517,000. Sycomore Asset Management lifted its holdings in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after buying an additional 4,079 shares during the period. Exome Asset Management LLC boosted its stake in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after acquiring an additional 525 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Analysts Set New Price Targets
Several research analysts have issued reports on the company. Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Barclays increased their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Robert W. Baird cut their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research report on Tuesday, March 18th. Finally, Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $611.86.
Insiders Place Their Bets
In other news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at $2,793,033.06. The trade was a 60.72 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 in the last quarter. 0.90% of the stock is currently owned by insiders.
Intuitive Surgical Trading Down 3.2 %
Shares of ISRG stock opened at $491.84 on Friday. The stock has a market capitalization of $175.18 billion, a price-to-earnings ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The stock’s 50-day moving average price is $556.28 and its 200-day moving average price is $532.34.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Investing In Preferred Stock vs. Common Stock
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Invest in Blue Chip Stocks
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.